Nonspecific active immunotherapy in the combined treatment of malignant neoplasms
Grinevich, I.A.
Vrachebnoe Delo 5: 8-11
1991
ISSN/ISBN: 0049-6804 PMID: 1866926 Document Number: 384491
Document emailed within 1 workday
Related Documents
Markowska, J. 1985: Immunology of malignant ovarian neoplasms. II. Nonspecific immunity and the effect of treatment Ginekologia Polska 56(4): 202-206Zakharychev, V.D.; Dedkov, I.P.; Chernichenko, V.A. 1975: Combined treatment of malignant neoplasms of the mediastimun Grudnaia Khirurgiia 1: 98-104
Koraszewska-Matuszewska, B.; Samochowiec-Donocikowa, E.; Bohosiewicz, J.; Kamińska-Olechnowiczowa, B. 1988: Combined treatment of malignant neoplasms of the visual system in children Klinika Oczna 90(7): 250-251
Mellstedt, H.åk.; Veelken, H. 2005: Active immunotherapy in patients with hematologic and solid neoplasms Onkologie 28(Suppl 4): 4-8
Matthias, M. 1975: Chemo- and immunotherapy of malignant neoplasms Zeitschrift für Arztliche Fortbildung 69(11): 580-584
Lotem, M.; Shiloni, E.; Ingber, A.; Peretz, T. 1997: Active specific immunotherapy of malignant melanoma Harefuah 133(3-4): 122-126
Sugimachi, K.; Ageo, H.; Natsuda, Y.; Yasaka, A.; Nakamura, T. 1979: Postoperative long-term chemotherapy combined with immunotherapy in esophageal neoplasms Nihon Kyobu Geka Gakkai 27(4): 504-506
Mutzner, P.A.; Stuhlmiller, G.M.; Seigler, H.F.; Stumpf, W.E.; Sar, M. 1981: Basis for a specific-active immunotherapy in malignant melanoma Schweizerische Medizinische Wochenschrift 111(36): 1322-1325
Romodanov, S.A.; Zatula, D.G.; Lisianyĭ, N.I.; Glavatskiĭ, A.Ia.; Prosvirneva, G.M. 1986: Efficacy of experimental active specific immunotherapy and immunoprevention of malignant gliomas of the brain Zhurnal Voprosy Neirokhirurgii Imeni N. N. Burdenko 1986(3): 18-23
Spitler, L.E.; Wong, P.; Sagebiel, R. 1978: Combined immunotherapy of malignant melanoma. Unusual survival following cerebral metastasis Archives of Dermatology 114(10): 1501-1504
Morisaki, T.; Matsumoto, K.; Kuroki, H.; Kubo, M.; Baba, E.; Onishi, H.; Tasaki, A.; Nakamura, M.; Inaba, S.; Katano, M. 2003: Combined immunotherapy with intracavital injection of activated lymphocytes, monocyte-derived dendritic cells and low-dose OK-432 in patients with malignant effusion Anticancer Research 23(6a): 4459-4465
Fioretti, P.; Gadducci, A.; Facchini, V.; Del Bravo, B.; Manfredini, C. 1988: Combined pharmacologic and surgical therapy of epithelial malignant neoplasms of the ovary in FIGO stages III-IV Annali di Ostetricia Ginecologia Medicina Perinatale 109(4): 191-198
2014: Modern cancer treatment by active immunotherapy Versicherungsmedizin 66(1): 48-49
Stolinsky, D.C.; Hum, G.J.; Jacobs, E.M.; Solomon, J.; Bateman, J.R. 1973: Clinical trial of weekly doses of vinblastine (NSC-49842) combined with vincristine (NSC-67574) in malignant lymphomas and other neoplasms Cancer ChemoTherapy Reports 57(4): 477-480
Mathé, G.; Hayat, M.; Amiel, J.L.; Schwarzenberg, L.; Schneider, M.; Pouillart, P.; Cattan, A. 1971: Active immunotherapy in the treatment of experimental leukemias and acute lymphoblastic leukemia in man Bollettino dell'Istituto Sieroterapico Milanese 50(4): 251-259
Kristensen, E. 1976: Use of immunotherapy in the treatment of malignant melanoma of the skin Ugeskrift for Laeger 138(8): 468-473
Kirkin, B.V. 1988: Hemosorption in the combined treatment of nonspecific ulcerative colitis Sovetskaia Meditsina 3: 7-10
Ivanova, L.A. 1994: Immunotherapy in the combined treatment of chronic destructive pulmonary tuberculosis Problemy Tuberkuleza 3: 16-19
Mathé, G.; Pouillart, P.; Schwarzenberg, L. 1973: Trials of active immunotherapy in the treatment of acute lymphoid leukemia: influence of diverse factors on the results Annales de Medecine Interne 124(5): 443-448
Clavel, B. 1974: Medical treatment of malignant bone tumors (carcinolytics, hormonotherapy, immunotherapy) La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 50(4): 287-295